Streetbeat News

Analyst Ratings

RBOT

Piper Sandler analyst Adam Maeder has maintained a Neutral rating on Vicarious Surgical (NYSE:RBOT) and lowered the price target from $1.5 to $1.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:03 pm

PASG

Canaccord Genuity analyst Whitney Ijem reiterates a Buy rating on Passage Bio (NASDAQ:PASG) and maintains a $14 price target.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:03 pm

HLAN

Piper Sandler analyst Justin Crowley reinstates Heartland Bancorp (OTC:HLAN) with an Overweight rating and sets a price target of $101.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:02 pm

GTLB

Canaccord Genuity analyst Kingsley Crane has reiterated a Buy rating on GitLab (NASDAQ:GTLB) and maintained a $74 price target.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 2:01 pm

T

Eight analysts have recently updated their ratings on AT&T (NYSE:T), showing a mix of bullish and somewhat bullish perspectives with an average 12-month price target of $22.00, up from $20.33. The updates include raised price targets and new ratings, reflecting a positive outlook on AT&T's performance, particularly noting its revenue growth, strong market capitalization, and effective debt management. The company's core business in wireless services and fixed-line services contributes significantly to its revenue, with a notable presence in Mexico and a 70% equity stake in DirecTV.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 2:00 pm

HAYW

Over the past three months, Hayward Holdings (NYSE:HAYW) received four indifferent analyst ratings. The average 12-month price target was raised to $14.25, up 11.07% from the previous $12.83. Analysts from Stifel, Goldman Sachs, and Jefferies adjusted their price targets, reflecting a positive outlook on the company's performance, including a 7.53% revenue growth and a net margin of 11.15%. However, concerns were noted regarding its ROE and ROA, which are below industry averages.

Portfolio Pulse from Benzinga Insights

March 05, 2024 | 2:00 pm

NKTX

Mizuho analyst Salim Syed has maintained a Buy rating on Nkarta (NASDAQ:NKTX) and significantly increased the price target from $9 to $31, indicating a strong positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:58 pm

AAPL

Jim Cramer expressed skepticism about Apple Inc's (AAPL) short-term prospects due to ongoing turbulence in its China market, particularly after a 24% drop in iPhone sales in the first six weeks of 2024. He advised waiting for a significant price drop before rebuilding a position in AAPL. Contrarily, analyst Gene Munster is optimistic about Apple's AI potential, predicting a significant earnings impact and a $33 billion annual opportunity.

Portfolio Pulse from Benzinga Neuro

March 05, 2024 | 1:58 pm

AKYA

Canaccord Genuity analyst Kyle Mikson reiterates a Buy rating on Akoya Biosciences (NASDAQ:AKYA) and maintains a $10 price target.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:58 pm

DSP

Craig-Hallum analyst Jason Kreyer maintains a Buy rating on Viant Technology (NASDAQ:DSP) and raises the price target from $8 to $14.

Portfolio Pulse from Benzinga Newsdesk

March 05, 2024 | 1:56 pm